Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 7/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.69 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.69 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.65 |
| ▸ | HPGD | P15428 | 1/20 | 0.65 |
| ▸ | ATM | Q13315 | 1/20 | 0.65 |
| ▸ | CA2 | P00918 | 3/20 | 0.64 |
| ▸ | CA1 | P00915 | 2/20 | 0.64 |
| ▸ | CA7 | P43166 | 2/20 | 0.64 |
| ▸ | HTT | P42858 | 1/20 | 0.64 |
| ▸ | CA12 | O43570 | 1/20 | 0.64 |
| ▸ | CA4 | P22748 | 1/20 | 0.64 |
| ▸ | CA6 | P23280 | 1/20 | 0.64 |
| ▸ | CA5A | P35218 | 1/20 | 0.64 |
| ▸ | CA9 | Q16790 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethiazide SCHEMBL30561875 | 1.00 | TDP1 (1.00) | TDP1LMNAALDH1A1CYP2C9CYP1A2 | |
| SCHEMBL29925887 | 0.90 | TDP1 (0.82) | TDP1LMNAALDH1A1CYP2C9CYP1A2 | |
| SCHEMBL13685945 | 0.88 | TDP1 (0.79) | TDP1LMNAALDH1A1CYP2C9CYP1A2 | |
| SCHEMBL11038368 | 0.87 | TDP1 (0.77) | TDP1LMNAALDH1A1CYP2C9CYP1A2 | |
| Buthiazide SCHEMBL29364486 | 0.86 | TDP1 (0.76) | TDP1LMNAALDH1A1CYP2C9CYP1A2 | |
| SCHEMBL13685954 | 0.86 | TDP1 (0.76) | TDP1LMNAALDH1A1CYP2C9CYP1A2 | |
| Buthiazide SCHEMBL309110 | 0.86 | TDP1 (0.76) | TDP1LMNAALDH1A1CYP2C9CYP1A2 | |
| Hydrochloric Acid SCHEMBL8972490 | 0.85 | TDP1 (0.74) | TDP1LMNAALDH1A1CYP2C9CYP1A2 | |
| SCHEMBL7366786 | 0.84 | TDP1 (0.72) | TDP1LMNAALDH1A1CYP2C9CYP1A2 | |
| SCHEMBL9810161 | 0.83 | TDP1 (0.71) | TDP1LMNAALDH1A1CYP2C9CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2987 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240002935-A1 | GENETIC METHOD FOR DIAGNOSIS AND TREATMENT OF PRE AND POST CORONAVIRUS INFECTIONS | GENETICURE INC. | 2024-01-04 | — | — | US | claimed |
| WO-2023096930-A1 | METHODS FOR NONINVASIVE MONITORING OF BRONCHOPULMONARY DYSPLASIA | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2023-06-01 | — | — | WO | claimed |
| CN-115921102-A | Multi-metal ore dressing process suitable for low-grade associated lead, copper and zinc in iron ore dressing tailings | 西北矿冶研究院 | 2023-04-07 | — | — | CN | claimed |
| CN-113182081-B | Flotation reagent and method for flotation separation of bismuth-zinc-sulfur polymetallic sulfide ore | 赣州有色冶金研究所有限公司 | 2023-03-24 | — | — | CN | claimed |
| EP-4132653-A1 | GENETIC METHOD FOR DIAGNOSIS AND TREATMENT OF PRE AND POST CORONAVIRUS INFECTIONS | Geneticure Inc. (US) | 2023-02-15 | — | — | EP | claimed |
| CN-114392834-B | Beneficiation method for associated low-grade copper, lead, zinc and silver in gold ore and application | 矿冶科技集团有限公司 | 2022-06-17 | — | — | CN | claimed |
| CN-114392834-A | Beneficiation method and application of associated low-grade copper, lead, zinc and silver in gold ore | 矿冶科技集团有限公司 | 2022-04-26 | — | — | CN | claimed |
| CN-113083512-B | Method for promoting flotation of copper oxide ores | 中南大学 | 2022-01-14 | — | — | CN | claimed |
| CN-113182081-A | Flotation reagent and method for flotation separation of bismuth-zinc-sulfur polymetallic sulfide ore | 赣州有色冶金研究所有限公司 | 2021-07-30 | — | — | CN | claimed |
| CN-113083512-A | Method for promoting flotation of copper oxide ores | 中南大学 | 2021-07-09 | — | — | CN | claimed |
| EP-0580860-B1 | METHOD OF MANUFACTURING SOLID DISPERSION | NIPPON SHINYAKU CO LTD (JP) | 1997-10-22 | — | — | EP | claimed |
| EP-0753301-A1 | Combination of benzimidazoles having angiotensin-II antagonistic activity with diuretics | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-01-15 | — | — | EP | claimed |
| EP-0591432-A4 | SOLUBILITY PARAMETER BASED DRUG DELIVERY SYSTEM AND METHOD FOR ALTERING DRUG SATURATION CONCENTRATION. | NOVEN PHARMA (US) | 1995-05-17 | — | — | EP | claimed |
| EP-0643580-A4 | COMBINATIONS OF ACE INHIBITORS AND DIURETICS. | — | 1995-04-19 | — | — | EP | claimed |
| EP-0643580-A1 | COMBINATIONS OF ACE INHIBITORS AND DIURETICS | MERCK & CO. INC. (US) | 1995-03-22 | — | — | EP | claimed |
| EP-0628313-A1 | Combination of benzimidazoles having angiotensin-II antagonistic activity with dinretics or calcium antagonists | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-12-14 | — | — | EP | claimed |
| WO-1994009778-A1 | COMBINATIONS OF ANGIOTENSIN-II RECEPTOR ANTAGONISTS AND DIURETICS | MERCK & CO., INC. (US) | 1994-05-11 | — | — | WO | claimed |
| EP-0591432-A1 | SOLUBILITY PARAMETER BASED DRUG DELIVERY SYSTEM AND METHOD FOR ALTERING DRUG SATURATION CONCENTRATION | NOVEN PHARMACEUTICALS, INC. (US) | 1994-04-13 | — | — | EP | claimed |
| WO-1993017685-A1 | COMBINATIONS OF ACE INHIBITORS AND DIURETICS | MERCK & CO., INC. (US) | 1993-09-16 | — | — | WO | claimed |
| US-4075335-A | HYPOTENSIVE AGENTS | CIBA-GEIGY CORPORATION (US) | 1978-02-21 | — | — | US | claimed |